Sponsor Pipeline

Chengdu Ucello Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Early Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07274059 Allogeneic UCB-derived CAR-T for SLE SLE - Systemic Lupus Erythematosus Recruiting
NCT07266311 CAR-T for Claudin18.2 Positive Solid Tumors Claudin18.2 Positive Advanced Solid Tumors Not Yet Recruiting
NCT07266337 CD19/BCMA CAR-T for SLE SLE - Systemic Lupus Erythematosus Not Yet Recruiting
Disease Areas
Lupus (SLE) (2)
Get alerts when Chengdu Ucello Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free